FDA to approve COVID-19 booster shots for immunocompromised people

Print Friendly, PDF & Email

NEW YORK— According to published reports, the Food and Drug Administration is expected to approve COVID-19 vaccine booster shots this week.

The FDA amendment of the emergency use authorizations for the Pfizer and Modern vaccines would allow anyone with compromised immune systems to get a third dose.

The move, which could come as early as today, comes after a panel of advisers to the Centers for Disease Control and Prevention recommended the move last month.

“The FDA is closely monitoring data as it becomes available from studies administering an additional dose of the authorized COVID-19 vaccines to immunocompromised individuals,” said an FDA spokesperson.

“The agency, along with the CDC, is evaluating potential options on this issue, and will share information in the near future.”

The CDC says that around 9 million adults in the US are immunocompromised, including organ transplant recipients, cancer patients, those with HIV among others.



Comments are closed.